☆ 4.6 Letter

Brodalumab in the treatment of moderate to severe psoriasis in patients when previous anti-interleukin 17A therapies have failed

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)

Get Full Text
Add to Collection

Journal

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 81, Issue 3, Pages 857-859

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2019.05.007

Keywords

-

Categories

Dermatology

Funding

  1. Ortho Dermatologics

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.